The U.S. Food & Drug Administration has approved Johnson & Johnson's device for a type of condition which causes abnormal ...
Shares of Johnson & Johnson JNJ inched 0.07% higher to $158.35 Tuesday, on what proved to be an all-around great trading ...
Guggenheim raised the firm’s price target on Johnson & Johnson to $162 from $156 and keeps a Neutral rating on the shares. The firm ...
I am hoping you will publish this piece I’ve written to amplify my voice to give hope to the hundreds of women in Pennsylvania and the tens of thousands of women across the country who were poisoned ...